Transparency Life Sciences
Transparency Life Sciences helps organizations extract insights from data without manual setup or coding by providing an automated AI analytics platform. It uses AI models to ingest and analyze both structured and unstructured data, delivering end-to-end analytics workflows with no required infrastructure or user coding. The product functions as a B2B SaaS analytics solution that automates data preparation, modeling, and reporting for business teams and analysts. Key technologies include machine learning/AI for natural language and data understanding and automated pipeline orchestration. The platform targets enterprises that need rapid, low-friction data analysis at scale across varied data types.
Transparency Life Sciences
Transparency Life Sciences helps organizations extract insights from data without manual setup or coding by providing an automated AI analytics platform. It uses AI models to ingest and analyze both structured and unstructured data, delivering end-to-end analytics workflows with no required infrastructure or user coding. The product functions as a B2B SaaS analytics solution that automates data preparation, modeling, and reporting for business teams and analysts. Key technologies include machine learning/AI for natural language and data understanding and automated pipeline orchestration. The platform targets enterprises that need rapid, low-friction data analysis at scale across varied data types.
TL;DR
Founded: 2012
Headquarters: New York, NY
Business: Digital/crowdsourcing drug development services (patient-centric clinical trials)
Last disclosed funding: Series A, Feb 15, 2018 (lead: New Ventures III)
Company Overview
Problem Domain
Clinical development and drug trials
Founded
2012
Industry
Biotechnology
Funding Track Record
Investor Signal
“New Ventures III led Series A”